Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Norley

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Plos One|August 23, 2017
No significant HTLV seroprevalence in German people who inject drugsOliver Hohn, Stephen Norley, Claudia Kücherer, et al.
Viral Immunology|September 22, 2006
Sustained conservation of CD4+ T cells in multiprotein triple modality-immunized rhesus macaques after intrarectal challenge with simian immunodeficiency virusNicole Stolte-Leeb, Ulrike Sauermann, Stephen Norley, et al.
Medicine|March 16, 2017
Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine: Phase IIb study protocolEva van Doorn, Heng Liu, Tamar Ben-Yedidia, et al.
Intervirology|February 5, 2003
Vaccine development using the simian immunodeficiency virus model for AIDSStephen Norley, Brigitte Beer, Doris Binninger-Schinzel, et al.
Journal of Virology|October 9, 2002
Engineered CD4- and CXCR4-using simian immunodeficiency virus from African green monkeys is neutralization sensitive and replicates in nonstimulated lymphocytesRenate R König, Egbert Flory, Stefanie Steidl, et al.
Virology|January 26, 2010
SIVagm containing the SHIV89.6P Envelope gene replicates poorly and is non-pathogenicMario Perković, Stephen Norley, Ralf Sanzenbacher, et al.
Journal of Medical Virology|December 22, 2007
Characterization of a chemokine receptor CCR5-negative T cell line and its use in determining human immunodeficiency virus type 1 phenotypeDorothea Binninger-Schinzel, Daniela Müller, Timo Wolf, et al.
Virology|December 22, 2015
Suppressing active replication of a live attenuated simian immunodeficiency virus vaccine does not abrogate protection from challengeBenjamin Gabriel, Uwe Fiebig, Oliver Hohn, et al.
Retrovirology|June 24, 2009
Role of complement and antibodies in controlling infection with pathogenic simian immunodeficiency virus (SIV) in macaques vaccinated with replication-deficient viral vectorsBarbara Falkensammer, Barbara Rubner, Alexander Hiltgartner, et al.
BMC Infectious Diseases|April 6, 2017
Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trialEva van Doorn, Olga Pleguezuelos, Heng Liu, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Plos One|August 23, 2017
No significant HTLV seroprevalence in German people who inject drugsOliver Hohn, Stephen Norley, Claudia Kücherer, et al.
Viral Immunology|September 22, 2006
Sustained conservation of CD4+ T cells in multiprotein triple modality-immunized rhesus macaques after intrarectal challenge with simian immunodeficiency virusNicole Stolte-Leeb, Ulrike Sauermann, Stephen Norley, et al.
Medicine|March 16, 2017
Evaluating the immunogenicity and safety of a BiondVax-developed universal influenza vaccine (Multimeric-001) either as a standalone vaccine or as a primer to H5N1 influenza vaccine: Phase IIb study protocolEva van Doorn, Heng Liu, Tamar Ben-Yedidia, et al.
Intervirology|February 5, 2003
Vaccine development using the simian immunodeficiency virus model for AIDSStephen Norley, Brigitte Beer, Doris Binninger-Schinzel, et al.
Journal of Virology|October 9, 2002
Engineered CD4- and CXCR4-using simian immunodeficiency virus from African green monkeys is neutralization sensitive and replicates in nonstimulated lymphocytesRenate R König, Egbert Flory, Stefanie Steidl, et al.
Virology|January 26, 2010
SIVagm containing the SHIV89.6P Envelope gene replicates poorly and is non-pathogenicMario Perković, Stephen Norley, Ralf Sanzenbacher, et al.
Journal of Medical Virology|December 22, 2007
Characterization of a chemokine receptor CCR5-negative T cell line and its use in determining human immunodeficiency virus type 1 phenotypeDorothea Binninger-Schinzel, Daniela Müller, Timo Wolf, et al.
Virology|December 22, 2015
Suppressing active replication of a live attenuated simian immunodeficiency virus vaccine does not abrogate protection from challengeBenjamin Gabriel, Uwe Fiebig, Oliver Hohn, et al.
Retrovirology|June 24, 2009
Role of complement and antibodies in controlling infection with pathogenic simian immunodeficiency virus (SIV) in macaques vaccinated with replication-deficient viral vectorsBarbara Falkensammer, Barbara Rubner, Alexander Hiltgartner, et al.
BMC Infectious Diseases|April 6, 2017
Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trialEva van Doorn, Olga Pleguezuelos, Heng Liu, et al.
Pageof 3